FDA says current dose of GSK, Vir COVID therapy likely not effective against BA.2 variant
The FDA’s move comes as a blow to the companies which have seen high demand for Sotrovimab after it became one of the few COVID-19…
Recover your password.
A password will be e-mailed to you.